Abstract
Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types of small peptides and their associated mechanistic actions against tumors are discussed, postulating their use as alternative treatments for HCC.
Keywords: Protein peptide, liver cancer, diagnosis, therapy, hepatocellular carcinoma
Protein & Peptide Letters
Title: The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma
Volume: 16 Issue: 5
Author(s): Felice H. Tsang, Nikki P. Lee and John M. Luk
Affiliation:
Keywords: Protein peptide, liver cancer, diagnosis, therapy, hepatocellular carcinoma
Abstract: Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types of small peptides and their associated mechanistic actions against tumors are discussed, postulating their use as alternative treatments for HCC.
Export Options
About this article
Cite this article as:
Tsang H. Felice, Lee P. Nikki and Luk M. John, The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167860
DOI https://dx.doi.org/10.2174/092986609788167860 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Natural Antioxidants: Therapeutic Prospects for Cancer and Neurological Diseases
Mini-Reviews in Medicinal Chemistry Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Current Pharmaceutical Design Targeting Schistosome Histone Modifying Enzymes for Drug Development
Current Pharmaceutical Design Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets High Resolution Protein Display by Two-Dimensional Electrophoresis
Current Analytical Chemistry Targeting Gene Therapy for Prostate Cancer
Current Pharmaceutical Design Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Antiproliferative Activity of Cobra Venom Cytotoxins
Current Topics in Medicinal Chemistry Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine Synthetic Peptides As Non-Viral DNA Vectors
Current Gene Therapy Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug Response
Current Pharmaceutical Design Pathobiology and Therapeutic Implications of Tumor Acidosis
Current Medicinal Chemistry Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay
Current Drug Targets Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
Mini-Reviews in Medicinal Chemistry